Midostaurin |
PKC-412; PKC-412A; CGP-41231; CGP-41251 |
Approved |
Novartis Pharma Ag |
Rydapt |
EU |
Leukemia, Myeloid, Acute; Mastocytosis |
Novartis Europharm Ltd |
2017-04-28 |
Leukemia; Hematologic Neoplasms; Mastocytosis, Systemic; Leukemia, Mast-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Hepatic Insufficiency; Leukemia, Myeloid, Acute; Mastocytosis |
Details
|
Ancestim |
AMJ-9302 |
Approved |
Amgen Inc |
Stemgen |
|
|
|
|
Hematopoietic stem cell transplantation (HSCT) |
Details
|
Imatinib mesylate |
CGP-57148B; CGP-57148; STI-571; QTI-571; CTI-571; AER-901; VR325 |
Approved |
Novartis Pharma Ag |
glivic, 格列卫, Gleevec, Ruvise, Glivec, Gleevec/Glivec |
United States |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
Novartis Pharma Ag |
2001-05-10 |
Chronic eosinophilic leukemia (CEL); Prostatic Diseases; Myelodysplastic-Myeloproliferative Diseases; Acute Lung Injury; Leukemia, Myeloid, Acute; Urogenital Neoplasms; Pulmonary Edema; Philadelphia Chromosome; Gastrointestinal Stromal Tumors; Leukemia, Myeloid, Chronic-Phase; Neurofibrosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostatic Neoplasms; Pulmonary Arterial Hypertension; Chordoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Respiratory Distress Syndrome, Adult; Leukemia, Myelomonocytic, Chronic; Glioblastoma; Dermatofibrosarcoma; Mastocytosis, Systemic; Myelodysplastic Syndromes; Coronavirus Disease 2019 (COVID-19); Rhinitis, Allergic, Seasonal; Genital Neoplasms, Male; Abdominal Neoplasms; Leukemia; Genital Diseases, Male; Hypereosinophilic Syndrome |
Details
|
Pexidartinib |
PLX-3397 |
Approved |
Daiichi Sankyo Co Ltd |
Turalio |
United States |
Giant Cell Tumor of Tendon Sheath |
Daiichi Sankyo Inc |
2019-08-02 |
Giant Cell Tumor of Tendon Sheath; Solid tumours; Synovitis, Pigmented Villonodular; Hodgkin Disease; Arthritis, Rheumatoid; Glioblastoma; Giant Cell Tumors; Prostatic Neoplasms; Gastrointestinal Stromal Tumors; Leukemia, Myeloid, Acute |
Details
|
Cabozantinib S-malate |
XL-184; BMS-907351 |
Approved |
Exelixis Inc |
Cometriq, Cabometyx |
Japan |
Carcinoma, Renal Cell |
Takeda |
2012-11-29 |
Solid tumours; Carcinoma, Renal Cell; Stomach Neoplasms; Pain; Esophageal Neoplasms; Glioblastoma; Kidney Diseases; Prostatic Neoplasms; Colorectal Neoplasms; Astrocytoma; Hepatic Insufficiency; Thyroid Neoplasms; Carcinoma, Neuroendocrine; Lymphoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung |
Details
|
Avapritinib |
BLU-285; CS-3007 |
Approved |
Blueprint Medicines Corp |
Ayvakit, Ayvakyt, 泰吉华 |
Hong Kong |
Gastrointestinal Stromal Tumors |
Cstone Pharmaceuticals |
2020-01-09 |
Solid tumours; Hematologic Neoplasms; Mastocytosis, Systemic; Leukemia, Mast-Cell; Central Nervous System Neoplasms; Gastrointestinal Stromal Tumors |
Details
|
Pazopanib Hydrochloride |
GW-786034; SB-786034; GSK-786034; GW-786034B |
Approved |
Glaxosmithkline Plc, Novartis Pharma Ag |
维全特, Armala, Patorma, Votrient |
Mainland China |
Carcinoma, Renal Cell |
Novartis Pharma Schweiz Ag |
2009-10-19 |
Osteosarcoma; Macular Degeneration; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular; Fallopian Tube Neoplasms; Glioma; Peritoneal Neoplasms; Colorectal Neoplasms; Prostatic Neoplasms; Ovarian Neoplasms; Breast Neoplasms; Sarcoma; Pancreatic Neoplasms; Small Cell Lung Carcinoma; Hemangiosarcoma; Carcinoma, Renal Cell; Solid tumours; Chondrosarcoma; Telangiectasia, Hereditary Hemorrhagic |
Details
|
Ripretinib |
DCC-2618 |
Approved |
Deciphera |
Qinlock, 擎乐 |
United Kingdom |
Gastrointestinal Stromal Tumors |
Deciphera Pharmaceuticals Llc |
2020-05-15 |
Mastocytosis, Systemic; Gastrointestinal Stromal Tumors |
Details
|
Ponatinib Hydrochloride |
AP-24534; INCB-84344; AP24534 HCl; AP24534-HCL; AP24534 hydrochloride |
Approved |
Ariad |
Iclusig |
Japan |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
Otsuka Holdings Co Ltd |
2012-12-14 |
Leukemia; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Solid tumours; Hematologic Neoplasms; Blast Crisis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Philadelphia Chromosome; Leukemia, Myeloid, Chronic-Phase; Gastrointestinal Stromal Tumors; Leukemia, Myeloid, Acute; Lymphoma; Leukemia, Biphenotypic, Acute |
Details
|
Regorafenib |
DAST; BAY-73-4506 |
Approved |
Bayer Ag |
Resihance, Stivarga |
Mainland China |
Gastrointestinal Stromal Tumors |
Bayer Pharma Ag |
2012-09-27 |
Solid tumours; Carcinoma, Renal Cell; Rectal Neoplasms; Colonic Neoplasms; Colorectal Neoplasms; Gastrointestinal Stromal Tumors; Carcinoma, Hepatocellular; Gastrointestinal Neoplasms |
Details
|
Lenvatinib Mesylate |
MK-7902; ER-203492-00; E-7080 |
Approved |
Eisai Co Ltd |
Kisplyx, Lenvima, Lenvima/Kisplyx, 乐卫玛 |
Japan |
Endometrial Neoplasms |
Eisai Co Ltd |
2015-02-13 |
Liver Diseases; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular; Lymphoma; Thyroid Neoplasms; Endometrial Neoplasms; Hepatic Insufficiency; Sarcoma; Urinary Bladder Neoplasms; Solid tumours; Adenocarcinoma of Lung; Thyroid Carcinoma, Anaplastic; Kidney Diseases; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of Head and Neck; Renal Insufficiency; Carcinoma, Renal Cell; Liver Neoplasms; Biliary Tract Neoplasms |
Details
|
Olverembatinib |
D-824; GZD-824; APG-1351; GIBH-824; HQP-1351 |
Approved |
Guangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences |
耐立克 |
Mainland China |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase |
Guangzhou Shunjian Biomedical Technology Co Ltd |
2021-11-25 |
Solid tumours; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid; Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors |
Details
|
Anlotinib Dihydrochloride |
AL-3818 |
Approved |
Advenchen Laboratories, Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd |
福可维 |
Mainland China |
Small Cell Lung Carcinoma |
Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd |
2018-05-08 |
Endometrial Neoplasms; Cholangiocarcinoma; Nasopharyngeal Carcinoma; Urologic Neoplasms; Colorectal Neoplasms; Gastrointestinal Stromal Tumors; Bone Neoplasms; Sarcoma, Alveolar Soft Part; Gallbladder Neoplasms; Medullary thyroid cancer (MTC); Thyroid Neoplasms; Esophageal Squamous Cell Carcinoma; Lung Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Melanoma; Osteoma; Carcinoma, Renal Cell; Head and Neck Neoplasms; Solid tumours; Biliary Tract Neoplasms; Ovarian Neoplasms; Thoracic Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Genital Diseases, Female; Leiomyosarcoma; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Small Cell Lung Carcinoma; Lymphoma, Large B-Cell, Diffuse; Sarcoma, Synovial; Neuroendocrine Tumors; Sarcoma; Bile Duct Diseases |
Details
|
Sorafenib Tosylate |
NSC-724772; BAY-43-0006; BAY-43-9006; BAY-54-9085 |
Approved |
Onyx Pharmaceuticals Inc |
多吉美, Nexavar |
EU |
Thyroid Neoplasms |
Bayer Ag |
2005-12-01 |
Breast Neoplasms; Neoplasm Metastasis; Fasting; Melanoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Thyroid Neoplasms; Hepatitis C; Hepatitis B; Liver Neoplasms; Liver Diseases; Pancreatic Neoplasms; Kidney Diseases; Carcinoma; Carcinoma, Renal Cell; Kidney Neoplasms; Solid tumours; Ovarian Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
Details
|
Dasatinib Hydrate |
BMS-354825; NSC-732517 |
Approved |
Bristol-Myers Squibb Company |
施达赛, Spricel, Sprycel, Spraysel |
Mainland China |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
Bristol-Myers Squibb Pharma Eeig |
2006-06-28 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid; Leukemia, Lymphoid; Myelodysplastic Syndromes; Scleroderma, Systemic; Blast Crisis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostatic Neoplasms; Breast Neoplasms; Leukemia, Myeloid, Chronic-Phase; Leukemia, Myeloid, Acute; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung |
Details
|
Sunitinib Malate |
PHA-290940; SU-010398; SU-11248; GB-102; PNU-290940; SU-011248-L-malate salt; PNU-290940AD; PHA-290940AD |
Approved |
Pfizer Pharmaceuticals Ltd (China) |
Sutent, 索坦 |
Japan |
Pancreatic neuroendocrine tumors (pNET) |
Pfizer Inc |
2006-01-26 |
Breast Neoplasms; Retinal Vein Occlusion; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Macular Degeneration; Carcinoma, Hepatocellular; Urogenital Neoplasms; Urologic Neoplasms; Colorectal Neoplasms; Gastrointestinal Stromal Tumors; Diabetic macular oedema; Prostatic Neoplasms; Kidney Neoplasms; Neuroendocrine Tumors; Urologic Diseases; Kidney Diseases; Pancreatic Neoplasms; Pancreatic neuroendocrine tumors (pNET); Stomach Neoplasms; Carcinoma, Islet Cell; Carcinoma, Renal Cell; Liver Neoplasms; Solid tumours |
Details
|